ES2084275T3 - Compuestos de acido succinico. - Google Patents

Compuestos de acido succinico.

Info

Publication number
ES2084275T3
ES2084275T3 ES92302786T ES92302786T ES2084275T3 ES 2084275 T3 ES2084275 T3 ES 2084275T3 ES 92302786 T ES92302786 T ES 92302786T ES 92302786 T ES92302786 T ES 92302786T ES 2084275 T3 ES2084275 T3 ES 2084275T3
Authority
ES
Spain
Prior art keywords
group
isomers
carbon atoms
atom
succinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92302786T
Other languages
English (en)
Inventor
Fumiyasu Sato
Atsushi Tsubaki
Hiroshi Hokari
Nobuyuki Tanaka
Masaru Saito
Kenji Akahane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3142275A external-priority patent/JP2686861B2/ja
Priority claimed from JP3188416A external-priority patent/JP2686863B2/ja
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2084275T3 publication Critical patent/ES2084275T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C08G77/08—Preparatory processes characterised by the catalysts used
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Polymers (AREA)

Abstract

COMPUESTOS DE ACIDO SUCCINICO. COMPUESTOS DE ACIDO SUCCINICO CON LA FORMULA: EN DONDE A REPRESENTA UN GRUPO HETEROCICLICO, UN GRUPO CICLOALQUILO DE 3 A 8 ELEMENTOS O UN GRUPO FENILO QUE PUEDE TENER UNO O MAS SUBSTITUYENTES SELECCIONADOS DEL GRUPO DE UN ATOMO DE HALOGENO, UN GRUPO ALQUILO INFERIOR QUE TIENE DE 1 A 6 ATOMOS DE CARBONO; B REPRESENTA UN GRUPO AMINO BICICLICO QUE PUEDE TENER DE 1 A 2 ENLACES NO SATURADOS, CON LA CONDICION QUE B SE ENLACE AL ATOMO DE CARBONO DEL GRUPO CARBONILO EN EL ATOMO DE NITROGENO; R REPRESENTA UN ATOMO DE HIDROGENO O COMBINA CON ATOMOS DE CARBONO PARA FORMAR UN ENLACE QUIMICO; R1 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR QUE TIENE DE 1 A 6 ATOMOS DE CARBONO O UN GRUPO ARALQUILO QUE TIENE DE 7 A 10 ATOMOS DE CARBONO; CUANDO HAY UN ATOMO DE CARBONO ASIMETRICO, ENANTIOMEROS DEL MISMO Y MEZCLAS RACEMICAS DEL MISMO, CUANDO HAY ISOMEROS GEOMETRICOS, CADA ISOMERO GEOMETRICO, E-ISOMEROS DEL MISMO, ZISOMEROS DEL MISMO, CIS ISOMEROS DEL MISMO, Y TRANS-ISOMEROS DEL MISMO; Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO, INCREMENTAN LA SECRECION DE INSULINA Y TIENEN UNA ACTIVIDAD HIPOGLICEMICA, Y, DE ESTE MODO, SON UTILES PARA EL TRATAMIENTO DE LA DIABETES.
ES92302786T 1991-03-30 1992-03-30 Compuestos de acido succinico. Expired - Lifetime ES2084275T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3142275A JP2686861B2 (ja) 1991-03-30 1991-03-30 新規なベンジリデンコハク酸誘導体
JP3188416A JP2686863B2 (ja) 1991-04-25 1991-04-25 新規なベンジルコハク酸誘導体
JP36151991 1991-12-27

Publications (1)

Publication Number Publication Date
ES2084275T3 true ES2084275T3 (es) 1996-05-01

Family

ID=27318415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92302786T Expired - Lifetime ES2084275T3 (es) 1991-03-30 1992-03-30 Compuestos de acido succinico.

Country Status (12)

Country Link
US (1) US5202335A (es)
EP (1) EP0507534B1 (es)
KR (1) KR100192530B1 (es)
AT (1) ATE134615T1 (es)
AU (1) AU654331B2 (es)
CA (1) CA2062877C (es)
DE (1) DE69208496T2 (es)
DK (1) DK170973B1 (es)
ES (1) ES2084275T3 (es)
FI (1) FI102172B1 (es)
HK (1) HK1005449A1 (es)
NO (1) NO178371C (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0967204A4 (en) * 1997-01-29 2000-11-29 Kissei Pharmaceutical METHOD FOR THE PRODUCTION OF BENZYL succinic acid ester derivatives
FR2765578B1 (fr) * 1997-07-03 1999-09-10 Adir Procede de preparation d'un perhydroisoindole substitue
JP3277320B2 (ja) * 1997-08-28 2002-04-22 有機合成薬品工業株式会社 シス−ヘキサヒドロイソインドリン誘導体の製造方法
FR2777566B1 (fr) * 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2779428B1 (fr) * 1998-06-03 2001-05-18 Synthelabo Derives d'oxo-azacycloalcanes, leurs preparations et leurs applications en therapeutique
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
US7166301B1 (en) * 1999-05-21 2007-01-23 Kissei Pharmaceutical Co., Ltd. Immediate release medicinal compositions for oral use
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
KR20020092060A (ko) * 2001-06-01 2002-12-11 김정균 알콕시 작용성 그룹을 포함한 폴리실록산 화합물
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CA2565878A1 (en) * 2004-05-11 2005-11-17 Kissei Pharmaceutical Co., Ltd. Pharmaceutical composition for prevention or treatment of lipid metabolism disorder
WO2006003907A1 (ja) * 2004-07-01 2006-01-12 Kissei Pharmaceutical Co., Ltd. 血管内膜過増殖疾患の予防または治療剤
JP2008514549A (ja) * 2004-09-14 2008-05-08 エリクシアー ファーマシューティカルズ， インコーポレイテッド 制御された炭水化物消化のための併用療法
CN1634885B (zh) * 2004-11-09 2011-05-04 北京乐力健生物科技有限公司 米格列奈晶型及其制备方法
CN1324010C (zh) * 2005-01-12 2007-07-04 江苏省药物研究所 一种米格列奈的制备方法
KR20070102694A (ko) * 2005-01-31 2007-10-19 아지노모토 가부시키가이샤 혈당 강하제를 함유하는, 내당능 이상, 경계형 당뇨병,인슐린 저항성 및 고인슐린혈증 개선 또는 치료용 의약조성물
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AU2006311601A1 (en) * 2005-11-07 2007-05-18 Elixir Pharmaceuticals, Inc. Combinations of metformin and meglitinide
WO2009047797A2 (en) * 2007-10-08 2009-04-16 Ind-Swift Laboratories Limited Process for the preparation of perhydroisoindole derivative
KR20110074614A (ko) * 2009-03-19 2011-06-30 고쿠리츠 다이가쿠 호진 교토 다이가쿠 췌도 이미징용 분자 프로브 전구체 및 그 사용
SI2429995T1 (sl) 2009-05-15 2014-05-30 Novartis Ag Arilpiridini kot inhibitorji aldosteron sintaze
BRPI1012852A2 (pt) 2009-05-15 2018-06-19 Novartis Ag derivados de benzoxazolona como inibidores da sintase de aldoesterona
NZ596304A (en) 2009-05-28 2014-01-31 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
EP2435402B1 (en) 2009-05-28 2016-04-13 Novartis AG Substituted aminobutyric derivatives as neprilysin inhibitors
EP2993169B1 (en) 2009-11-17 2017-12-20 Novartis AG Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8575160B2 (en) 2009-11-30 2013-11-05 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
CN101973926B (zh) * 2010-11-05 2012-09-19 威海迪素制药有限公司 R-米格列奈钙的制备方法
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
WO2013189829A1 (en) 2012-06-22 2013-12-27 Laboratorios Lesvi, S. L. Process for obtaining (s)-2-benzyl-4-((3ar,7as)-hexahydro-1 h-isoindol- 2(3h)-yl)-4-oxobutanoic acid and salts thereof
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
LT2956464T (lt) 2013-02-14 2018-07-10 Novartis Ag Pakeisti bisfenilbutanoinės fosfonrūgšties dariniai, kaip nep (neutralios endopeptidazės) inhibitoriai
MX2016001021A (es) 2013-07-25 2016-08-03 Novartis Ag Bioconjugados de polipeptidos de apelina sinteticos.
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
CN106631978B (zh) * 2016-12-29 2020-03-24 千辉药业（安徽）有限责任公司 一种米格列奈中间体的合成工艺
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3689506D1 (de) * 1985-10-09 1994-02-17 Shell Int Research Neue Acrylsäureamide.
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DK41592D0 (da) 1992-03-27
NO921200L (no) 1992-10-01
US5202335A (en) 1993-04-13
DE69208496D1 (de) 1996-04-04
DE69208496T2 (de) 1996-10-17
FI921392A (fi) 1992-10-01
ATE134615T1 (de) 1996-03-15
FI102172B (fi) 1998-10-30
NO178371C (no) 1996-03-13
DK41592A (da) 1992-10-01
AU1280992A (en) 1992-10-01
DK170973B1 (da) 1996-04-09
HK1005449A1 (en) 1999-01-08
CA2062877C (en) 2002-07-02
CA2062877A1 (en) 1992-10-01
KR100192530B1 (ko) 1999-06-15
KR930019682A (ko) 1993-10-18
EP0507534A1 (en) 1992-10-07
NO921200D0 (no) 1992-03-27
NO178371B (no) 1995-12-04
FI921392A0 (fi) 1992-03-30
FI102172B1 (fi) 1998-10-30
EP0507534B1 (en) 1996-02-28
AU654331B2 (en) 1994-11-03

Similar Documents

Publication Publication Date Title
ES2084275T3 (es) Compuestos de acido succinico.
DE69331414T2 (de) Depsipeptide, herstellung und anwendung
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
TW370451B (en) Bicyclic amine derivatives
HK1032969A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
IE893246L (en) Biologically active compounds
HUT61656A (en) Herbicide composition containing 5-aryl-izoxazol derivatives as active components and process for producing the active components
KR890001989A (ko) 펜타디엔아미드
EP0312269A3 (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as h3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents ypocholesterolemic agents
ES8504115A1 (es) Un metodo de preparar nuevos compuestos de benzoilurea
HU9302395D0 (en) Method for producing 4-/(benzothiazolyl)-methyl-amino/-alpha-/(3,4-difluorine-phenoxi)-methyl/-1-piperidine-ethanol
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
KR970705540A (ko) 구아니디노메틸 사이클로헥산 카복실산 에스테르 유도체(Guanidinomethyl cyclohexane carboxylic ester derivative)
DE69006607D1 (de) Verfahren zur Herstellung von Carbamaten und dabei auftretende Zwischenprodukte.
NO169837C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive forbindelser
HUT49845A (en) Process for producing optically active n-substituted alanine derivatives with herbicidal effect

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 507534

Country of ref document: ES